PCRX EBITDA Growth
Pacira Biosciences Inc · EBITDA Growth
PCRX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-12.47%period ending
PCRX Quarterly EBITDA YoY % (-12.49% → -12.47%)
Year-over-year change
High-resolution chart · PNG
PCRX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -12.4654% | |
| -12.2051% | |
| -50.0326% | |
| 129.9493% | |
| -50.0734% | |
| -3.1469% | |
| -7.8404% | |
| -403.4616% | |
| -2.5199% | |
| 1,849.4944% | |
| 150.3214% | |
| 21.1243% | |
| 18.2018% | |
| -95.1091% | |
| 32.8026% | |
| -14.7647% | |
| 37.7171% | |
| 52.308% | |
| -31.6717% | |
| 107.0548% | |
| 1,272.0818% | |
| 26.0218% | |
| 239.8903% | |
| 13.1364% | |
| -77.3225% | |
| 192.7888% | |
| -60.7635% | |
| 85.1729% | |
| 9.3877% | |
| 337.5642% | |
| 35.3293% | |
| 802.1368% | |
| 200.6124% | |
| 80.7254% | |
| 1,090.5778% | |
| 105.3787% | |
| -247.2294% | |
| -1,436.7675% | |
| -49.8216% | |
| -440.6146% | |
| -270.7371% | |
| -68.3328% | |
| -78.8331% | |
| 302.2835% | |
| 333.0769% | |
| 149.372% | |
| 227.1854% | |
| 110.9843% | |
| 92.7984% | |
| 63.7061% | |
| 25.9338% | |
| 20.9111% | |
| -69.3137% | |
| -86.45% | |
| -3.9091% | |
| -89.7586% | |
| 20.8977% | |
| -63.0789% | |
| -140.7877% | |
| -32.7818% | |
| -75.9956% | |
| -70.1915% | |
| 30.8934% | |
| -12.4855% |